Amylyx Pharmaceuticals Inc.

Website

Amylyx Pharmaceuticals Inc. Ushering in a new era for treating diseases with high unmet needs

Our team believes in doing things the right way, and we’re fortunate to be led by people with a proven track record of t...
10/07/2026

Our team believes in doing things the right way, and we’re fortunate to be led by people with a proven track record of therapeutic development through commercialization in diseases with high unmet needs. Meet our leadership: https://www.amylyx.com/our-company/leadership-team

10/02/2026

Post-bariatric hypoglycemia (PBH) is a rare, chronic condition with no FDA-approved treatments. Among the roughly two million people who have had Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy in the past decade, an estimated 160,000 are living with PBH today.

The condition can cause debilitating low blood sugar episodes when the brain does not receive enough glucose. PBH can be difficult to diagnose as symptoms, such as brain fog, fatigue, sweating, blurred vision, and dizziness, can be non-specific, vary in severity, and/or be mistaken for dumping syndrome. Learn more about PBH on our website at https://bit.ly/4xYduiO.

09/28/2026

At Amylyx, we chart new territories with rigorous science. We match our investigational therapies with diseases where we believe they can make the greatest impact, based on well-defined mechanistic rationale, clear clinical outcomes and biomarkers, and rigorous preclinical data, agnostic of modality. Explore our scientific approach: https://bit.ly/4htXpuP

09/21/2026

At Amylyx, we’re rooted in connection—to each other, to our values, and to the communities we serve.

Our work is driven by a shared commitment to people living with serious diseases and the belief that we can make a difference together.

If you’re ready to bring your expertise and passion to work that matters, explore our open positions and join : https://bit.ly/4hnJc2F

09/16/2026

We recently celebrated five more 5-year anniversaries here at Amylyx: Junliang Chen, Steven de Vos, Michael DiRuzza, Cindy Goodman, Wade Harwick, Mark Petter, and Isabella Ulvestad! Thank you all for your leadership and commitment to our mission to develop novel therapies for communities with high unmet needs.

09/11/2026

Calpain-2 (CAPN2) is an important contributor to axonal degeneration, or nerve fiber damage, which plays a critical role in ALS progression.

Research indicates that calpain-2 activation can disrupt key cellular pathways and reduce the structural integrity of nerve fibers, contributing to neurodegeneration. Learn more about the connection between calpain-2 and ALS on our website at https://bit.ly/46Zdzrf.

09/09/2026

At Amylyx, collaboration, support, and continuous growth are key to our ways of working. Cody shares what’s stood out to him most about working at Amylyx and how a workplace built on learning, trust, and shared purpose has shared his experience. If you’re looking a place where you can grow professionally while contributing to meaningful work, is hiring: https://bit.ly/4A3UdyK

09/03/2026

Amylyx was founded with the intention of making a major impact on humanity.

If you want to focus your career on helping people who live with devastating diseases, this is an incredible time to join our team.

If you have passion to help others, we can’t wait to meet you. Apply here: https://bit.ly/4cXgmVo

is in Toronto this week for the International Federation for the Surgery and Other Therapies for Obesity’s XXIX IFSO W...
09/01/2026

is in Toronto this week for the International Federation for the Surgery and Other Therapies for Obesity’s XXIX IFSO World Congress. If you’re in attendance, we look forward to connecting with you!

08/26/2026

Every breakthrough starts with people like Amy Shabazz who are passionate about helping others and engaged in the work they do. At Amylyx, you'll join teams united by a shared mission and empowered to make a meaningful impact every day.

If you're ready to work besides a talented, thoughtful group of people who are determined to make a difference, we'd like to meet you.

Explore career opportunities: https://bit.ly/4zGBngU

Address

55 Cambridge Parkway, Suite 6W
Cambridge, MA
02142

Website

, ,

Alerts

Be the first to know and let us send you an email when Amylyx Pharmaceuticals Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share